Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
4.100
-0.230 (-5.31%)
At close: Jun 6, 2025, 4:00 PM
4.040
-0.060 (-1.46%)
After-hours: Jun 6, 2025, 6:02 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $44.39 million as of June 6, 2025. Its market cap has increased by 286.03% in one year.
Market Cap
44.39M
Enterprise Value
-79.85M
1-Year Change
286.03%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $44.39M, an increase of 28.68%. That is a compound annual growth rate of 2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 46.90M | -39.25% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.52B |
| Johnson & Johnson | 368.66B |
| AbbVie | 330.92B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.49B |
| Abbott Laboratories | 231.33B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |